Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gülşan Türköz Sucak"'
Autor:
Mehmet Sezgin Pepeler, Kadir Acar, Özlem Güzel Tunçcan, Ömer Uluoğlu, Ayşe Kalkancı, Hakan Atalar, Koray Kılıç, Gülsan Türköz Sucak
Publikováno v:
Case Reports in Hematology, Vol 2015 (2015)
Objective and Importance. Invasive mucormycosis may complicate the course of patients with hematologic malignancies and has a very high mortality rate. Early diagnosis and aggressive approach combined with surgical and medical treatment have paramoun
Externí odkaz:
https://doaj.org/article/4e2b92a0e8d241ddb41552a432f0c0b8
Autor:
Nurdan Köktürk, Fatma Yıldırım, Müge Aydoğdu, Şahika Zeynep Akı, Zeynep Arzu Yeğin, Zübeyde Nur Özkurt, Elif Suyanı, İpek Kıvılcım Oğuzülgen, Gülşan Türköz Sucak
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 1, Pp 34-40 (2016)
INTRODUCTION: Chemo/radiotherapy-induced free oxygen radicals and reactive oxygen derivatives contribute to the development of early and late transplantation-related pulmonary and extra-pulmonary complications in hematopoietic stem cell transplantati
Externí odkaz:
https://doaj.org/article/8b2bc4c3450040dd8fc7710565727d36
Autor:
Fergün Yılmaz, Nur Soyer, Güldane Cengiz Seval, Sinem Civriz Bozdağ, Pervin Topcuoğlu, Ali Ünal, Leylagül Kaynar, Gökhan Özgür, Gülsan Türköz Sucak, Hakan Göker, Mustafa Velet, Hakan Özdoğu, Mehmet Yılmaz, Emin Kaya, Ozan Salim, Burak Deveci, İhsan Karadoğan, Güray Saydam, Fahri Şahin, Filiz Vural
Publikováno v:
Turkish Journal of Hematology, Vol 38, Iss 3, Pp 195-203 (2021)
Objective: Although inhibition of the complement system at different steps is a promising therapy modality in patients with paroxysmal nocturnal hemoglobinuria (PNH), allogeneic hematopoietic stem cell transplantation (HCT) is still the only curative
Externí odkaz:
https://doaj.org/article/5bce8903a2b2414e88326fb73088f77a
Autor:
Kadir Acar, Şahika Zeynep Akı, Zübeyde Nur Özkurt, Gülendam Bozdayı, Seyyal Rota, Gülsan Türköz Sucak
Publikováno v:
Turkish Journal of Hematology, Vol 31, Iss 3, Pp 276-285 (2014)
OBJECTIVE: Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in allogeneic hematopoietic stem cell transplantation (AHSCT) recipients. Current practice includes prophylactic and preemptive treatment modalities, which have risks,
Externí odkaz:
https://doaj.org/article/97891b24404b4516b6bb666b2c66e8a3
Publikováno v:
Turkish Journal of Hematology, Vol 28, Iss 01, Pp 81-83 (2011)
Externí odkaz:
https://doaj.org/article/777da01bd2934affbe65d731abef71b7
Publikováno v:
Turkish Journal of Hematology, Vol 28, Iss 1, Pp 81-83 (2011)
Externí odkaz:
https://doaj.org/article/516788ec34c1477a8859afea11ed3cd2
Publikováno v:
Turkish Journal of Hematology, Vol 31, Iss 3, Pp 323-324 (2014)
Externí odkaz:
https://doaj.org/article/f5c7da9887a447579767c3b14165bca8
Publikováno v:
Turkish Journal of Hematology, Vol 30, Iss 1, Pp 81-82 (2013)
Externí odkaz:
https://doaj.org/article/8805bc2b9400462aaf22292c4e9a8c85
Publikováno v:
Turkish Journal of Hematology, Vol 29, Iss 3, Pp 301-302 (2012)
Externí odkaz:
https://doaj.org/article/9753081a4510426b8de0f30b383db7ef